RETN and metabolic dysfunction-associated steatotic liver disease: As a result, resistin takes part in many situations that trigger inflammation, such as atherosclerosis and cardiovascular disease (CVD), non-alcoholic fatty liver disease (NAFLD), osteoporosis, cancer, Crohn’s disease, metabolic diseases, DM2 and autoimmune diseases [17,18].